Extended-release lamotrigine in the treatment of patients with epilepsy

Bibliography

• Ferguson PL, Chiprich J, Smith G, Prevalence of self-reported epilepsy, health care access, and health behaviors among adults in South Carolina. Epilepsy Behav 2008;13:529-34
   PubMed Web of Science ®Google Scholar
• Kobau R, Zahran H, Grant D, Prevalence of active epilepsy and health-related quality of life among adults with self-reported epilepsy in California: California Health Interview Survey, 2003. Epilepsia 2007;48:1904-13
   PubMed Web of Science ®Google Scholar
• Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Health Styles Survey. Epilepsia 2006;47:1915-21
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Prevalence of self-reported epilepsy – United States, 1986 – 1990. MMWR Morb Mortal Wkly Rep 1994;43:810-11, 817-8
   PubMedGoogle Scholar
• From the Centers for Disease Control and Prevention. Prevalence of self-reported epilepsy – United States, 1986 – 1990. JAMA 1994;272:1893
   PubMed Web of Science ®Google Scholar
• Elliott JO, Moore JL, Lu B. Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 Behavioral Risk Factor Surveillance System. Epilepsy Behav 2008;12:434-44
   PubMed Web of Science ®Google Scholar
• Forsgren L, Hauser WA, Olafsson E, Mortality of epilepsy in developed countries: a review. Epilepsia 2005;46(Suppl 11):18-27
   PubMedGoogle Scholar
• Lhatoo SD, Sander JW. Cause-specific mortality in epilepsy. Epilepsia 2005;46(Suppl 11):36-9
   PubMedGoogle Scholar
• Nei M, Bagla R. Seizure-related injury and death. Curr Neurol Neurosci Rep 2007;7:335-41
   PubMed Web of Science ®Google Scholar
• Shackleton DP, Westendorp RG, Kasteleijn-Nolst Trenite DG, Survival of patients with epilepsy: an estimate of the mortality risk. Epilepsia 2002;43:445-50
   PubMed Web of Science ®Google Scholar
• Klenerman P, Sander JW, Shorvon SD. Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry 1993;56:149-52
   PubMed Web of Science ®Google Scholar
• Neufeld MY, Vishne T, Chistik V, Korczyn AD. Life-long history of injuries related to seizures. Epilepsy Res 1999;34:123-7
   PubMed Web of Science ®Google Scholar
• Faught E, Duh MS, Weiner JR, Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology 2008;71:1572-8
   PubMed Web of Science ®Google Scholar
• DiIorio C, Osborne Shafer P, Letz R, The association of stigma with self-management and perceptions of health care among adults with epilepsy. Epilepsy Behav 2003;4:259-67
   PubMed Web of Science ®Google Scholar
• Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002;3:338-42
   PubMed Web of Science ®Google Scholar
• Davis KL, Candrilli SD, Edin HM. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia 2008;49:446-54
   PubMed Web of Science ®Google Scholar
• Elwes RD, Johnson AL, Shorvon SD, Reynolds EH. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med 1984;311:944-7
   PubMed Web of Science ®Google Scholar
• First Seizure Trial Group (FIR.S.T. Group). Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 1993;43:478-83
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9
   PubMed Web of Science ®Google Scholar
• Noyer M, Gillard M, Matagne A, The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol 1995;286:137-46
   PubMed Web of Science ®Google Scholar
• Francis J, Burnham WM. 3[H]Phenytoin identifies a novel anticonvulsant-binding domain on voltage-dependent sodium channels. Mol Pharmacol 1992;42:1097-103
   PubMed Web of Science ®Google Scholar
• McLean MJ, Macdonald RL. Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 1986;238:727-38
   PubMed Web of Science ®Google Scholar
• Lang DG, Wang CM, Cooper BR. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther 1993;266:829-35
   PubMed Web of Science ®Google Scholar
• McLean MJ, Bukhari AA, Wamil AW. Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture. Epilepsia 2000;41(Suppl 1):S21-4
   PubMedGoogle Scholar
• Lloyd P, Flesch G, Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 1994;35(Suppl 3):S10-13
   PubMedGoogle Scholar
• Stephens WP, Coe JY, Baylis PH. Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine. Br Med J 1978;1:1445-7
   PubMed Web of Science ®Google Scholar
• Macdonald RL, McLean MJ. Anticonvulsant drugs: mechanisms of action. Adv Neurol 1986;44:713-36
   PubMedGoogle Scholar
• MacDonald RL, Twyman RE. Kinetic properties and regulation of GABAA receptor channels. Ion Channels 1992;3:315-43
   PubMedGoogle Scholar
• Study RE, Barker JL. Diazepam and (–)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 1981;78:7180-4
   PubMed Web of Science ®Google Scholar
• Sofou K, Kristjansdottir R, Papachatzakis NE, Management of prolonged seizures and status epilepticus in childhood: a systematic review. J Child Neurol 2009;24:918-26
   PubMed Web of Science ®Google Scholar
• Sills GJ, Brodie MJ. Update on the mechanisms of action of antiepileptic drugs. Epileptic Disord 2001;3:165-72
   PubMed Web of Science ®Google Scholar
• Luszczki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep 2009;61:197-216
   PubMed Web of Science ®Google Scholar
• Rheims S, Ryvlin P. Once-daily lamotrigine extended release for epilepsy management. Expert Rev Neurother 2009;9:167-73
   PubMed Web of Science ®Google Scholar
• Lamictal XR package insert (US). GlaxoSmithKline. 18 January 2010
   Google Scholar
• Hainsworth AH, Spadoni F, Lavaroni F, Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex. Neuropharmacology 2001;40:784-91
   PubMed Web of Science ®Google Scholar
• Poolos NP, Migliore M, Johnston D. Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nat Neurosci 2002;5:767-74
   PubMed Web of Science ®Google Scholar
• Huang CW, Huang CC, Liu YC, Wu SN. Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells. Epilepsia 2004;45:729-36
   PubMed Web of Science ®Google Scholar
• Valles AS, Garbus I, Barrantes FJ. Lamotrigine is an open-channel blocker of the nicotinic acetylcholine receptor. Neuroreport 2007;18:45-50
   PubMed Web of Science ®Google Scholar
• Rambeck B, Wolf P. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 1993;25:433-43
   PubMed Web of Science ®Google Scholar
• Werz MA. Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release. Ther Clin Risk Manag 2008;4:1035-46
   PubMedGoogle Scholar
• Sabers A, Ohman I, Christensen J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology 2003;61:570-1
   PubMed Web of Science ®Google Scholar
• Christensen J, Petrenaite V, Atterman J, Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia 2007;48:484-9
   PubMed Web of Science ®Google Scholar
• Tompson DJ, Ali I, Oliver-Willwong R, Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study). Epilepsia 2008;49:410-7
   PubMed Web of Science ®Google Scholar
• Fuller MA, Sajatovic M, editors. Drug information handbook for psychiatry: a comprehensive reference of psychotropic, non-psychotropic, and herbal agents. 6th edition. Lexi-Comp, Hudson, OH; 2006
   Google Scholar
• Naritoku DK, Warnock CR, Messenheimer JA, Lamotrigine extended-release as adjunctive therapy for partial seizures. Neurology 2007;69:1610-8
   PubMed Web of Science ®Google Scholar
• Faught RE, Weiner JR, Guerin A, Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia 2009;50:501-9
   PubMed Web of Science ®Google Scholar
• Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat 2007;3:117-31
   PubMedGoogle Scholar